PANTHERx, Rare Disease Pharmacy, to Distribute Tavneos in US

PANTHERx, Rare Disease Pharmacy, to Distribute Tavneos in US

309683

PANTHERx, Rare Disease Pharmacy, to Distribute Tavneos in US

Tavneos (avacopan), a recently approved add-on oral therapy for severe, active ANCA-associated vasculitis (AAV), will be distributed in the U.S. by PANTHERx, the country’s leading rare disease pharmacy. The announcement follows an agreement with ChemoCentryx, Tavneos’ developer, which selected the pharmacy as a limited distribution partner. “PANTHERx is proud to announce our partnership with ChemoCentryx for the distribution of Tavneos, a first-in-class orally administered novel medication,” Rob Snyder, president of PANTHERx Rare Pharmacy, said in a press release. “Together…

You must be logged in to read/download the full post.